This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Find out more here.

Am I eligible to receive the new Genetic Health Risk reports?

Important: This article is most applicable to existing 23andMe customers located in the United States. If you have not yet purchased with 23andMe, please see our Service Options help article. 

The majority of existing US customers who purchased the 23andMe service after November 22, 2013 are eligible to receive the new Genetic Health Risk* reports.

  • Customers who purchased the 23andMe Ancestry Service can receive the reports by upgrading to the Health + Ancestry Service for an additional $125. The option to upgrade is only available once sample processing is complete and data is returned. Once purchased, the new reports will be accessible in your account immediately upon purchasing an upgrade. Learn more.

  • Customers who purchased the 23andMe Health + Ancestry Service, which was introduced on September 21, 2016, are eligible to receive the new reports at no additional cost. You will be prompted to configure your reports selection to include or exclude these reports. If you decide to include these reports, they will appear in the Genetic Health Risk Report section of your account**. Sign in.

  • Customers who purchased between November 22, 2013 and September 21, 2016, received the Health + Ancestry Service and are eligible to receive these reports at no additional cost. You will be prompted to configure your reports selection to include or exclude these reports. If you decide to include these reports, they will appear in the Genetic Health Risk Reports section of your account**. Sign in.

  • Customers who purchased prior to November 22, 2013 are not eligible to receive these reports. Please note that the previous versions*** of the 23andMe health-related reports are available in the Reports Archive. To receive the new Genetic Health Risk reports, a genotyping chip update is needed. At this time, updating genotyping chips is not available as we continue to review our policy surrounding updating genotyping chips. Additional information will be made available in the coming months.

If you are eligible to receive the reports on genetic health risks, you will be prompted to configure your reports settings and once you have selected to include these reports, they will automatically be appear to your account in the Genetic Health Risk Reports section of your account.

Go to the Genetic Health Risk reports.

 

 *The 23andMe PGS test uses qualitative genotyping to detect clinically relevant variants in the genomic DNA of adults, from saliva collected using an FDA-cleared collection device (Oragene·DX model OGD-500.001) for the purpose of reporting and interpreting genetic health risks. The relevance of each report varies based on ethnicity. Our genetic health risk reports describe if a person has variants associated with a higher risk of developing a disease, but do not describe a person’s overall risk of developing the disease. The reports are not intended to diagnose any disease, tell you anything about your current state of health, or to be used to make medical decisions, including whether or not you should take a medication or how much of a medication you should take. The Late-onset Alzheimer’s Disease genetic health risk report is indicated for reporting of the ε4 variant in the APOE gene and describes if a person has a variant associated with an increased risk of developing late-onset Alzheimer’s disease. The ε4 variant included in this report is found and has been studied in many ethnicities. Detailed risk estimates have been studied the most in people of European descent. The Parkinson’s Disease genetic health risk report (i) is indicated for reporting of the G2019S variant in the LRRK2 gene, and the N370S variant in the GBA gene, (ii) describes if a person has variants associated with an increased risk of developing Parkinson’s disease, and (iii) is most relevant for people of European, Ashkenazi Jewish, and North African Berber descent.

**Sensitive reports (Late-onset Alzheimer’s Disease disease and Parkinson’s disease) require an additional opt in step to view. You can opt in to health reports generally, but opt out of one or both sensitive reports.

***Newly offered 23andMe reports may include different variants, formatting and language than older versions of reports on the same condition. Health-related reports previously visible to you in the old site experience will remain accessible to you through the Reports Archive.


Still have questions? Contact Us

Submit a request

Facebook

Twitter

Phone
1-800-239-5230
Mon - Fri
3am - 5pm PT
Follow
Was this article helpful?
2 out of 3 found this helpful